128 related articles for article (PubMed ID: 15755813)
1. Core 3 synthase is down-regulated in colon carcinoma and profoundly suppresses the metastatic potential of carcinoma cells.
Iwai T; Kudo T; Kawamoto R; Kubota T; Togayachi A; Hiruma T; Okada T; Kawamoto T; Morozumi K; Narimatsu H
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4572-7. PubMed ID: 15755813
[TBL] [Abstract][Full Text] [Related]
2. Impacts of β-1, 3-N-acetylglucosaminyltransferases (B3GNTs) in human diseases.
Xie A; Wang J; Liu Y; Li G; Yang N
Mol Biol Rep; 2024 Mar; 51(1):476. PubMed ID: 38553573
[TBL] [Abstract][Full Text] [Related]
3. Role of Post-Translational Modifications in Colorectal Cancer Metastasis.
Peng N; Liu J; Hai S; Liu Y; Zhao H; Liu W
Cancers (Basel); 2024 Feb; 16(3):. PubMed ID: 38339403
[TBL] [Abstract][Full Text] [Related]
4. Integrated analysis of necroptosis-related genes for evaluating immune infiltration and colon cancer prognosis.
Yang W; Lu S; Peng L; Zhang Z; Zhang Y; Guo D; Ma F; Hua Y; Chen X
Front Immunol; 2022; 13():1085038. PubMed ID: 36618366
[TBL] [Abstract][Full Text] [Related]
5. IGF2BP2 promotes pancreatic carcinoma progression by enhancing the stability of B3GNT6 mRNA via m6A methylation.
Cao P; Wu Y; Sun D; Zhang W; Qiu J; Tang Z; Xue X; Qin L
Cancer Med; 2023 Feb; 12(4):4405-4420. PubMed ID: 35908253
[TBL] [Abstract][Full Text] [Related]
6. O-Glycosylation Changes in Serum Immunoglobulin G Are Associated with Inflammation Development in Advanced Endometriosis.
Sołkiewicz K; Kacperczyk M; Krotkiewski H; Jędryka M; Kratz EM
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897676
[TBL] [Abstract][Full Text] [Related]
7. Specific (sialyl-)Lewis core 2
Madunić K; Mayboroda OA; Zhang T; Weber J; Boons GJ; Morreau H; van Vlierberghe R; van Wezel T; Lageveen-Kammeijer GSM; Wuhrer M
Theranostics; 2022; 12(10):4498-4512. PubMed ID: 35832079
[TBL] [Abstract][Full Text] [Related]
8. Applying transcriptomics to studyglycosylation at the cell type level.
Dworkin LA; Clausen H; Joshi HJ
iScience; 2022 Jun; 25(6):104419. PubMed ID: 35663018
[TBL] [Abstract][Full Text] [Related]
9. An etanercept O-glycovariant with enhanced potency.
Biel TG; Faison T; Matthews AM; Zou G; Ortega-Rodriguez U; Pegues MA; Azer N; Gomez F; Johnson S; Rogstad S; Chen K; Xie H; Agarabi C; Rao VA; Ju T
Mol Ther Methods Clin Dev; 2022 Jun; 25():124-135. PubMed ID: 35402630
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of B3GNT6 is a predictor of poor outcomes in patients with colorectal cancer.
Xiao S; Yang C; Zhang Y; Lai C
World J Surg Oncol; 2022 Apr; 20(1):110. PubMed ID: 35387659
[TBL] [Abstract][Full Text] [Related]
11. Finding the sweet spot: glycosylation mediated regulation of intestinal inflammation.
Brazil JC; Parkos CA
Mucosal Immunol; 2022 Feb; 15(2):211-222. PubMed ID: 34782709
[TBL] [Abstract][Full Text] [Related]
12. Robust Glycogene-Based Prognostic Signature for Proficient Mismatch Repair Colorectal Adenocarcinoma.
Li Y; Li D; Chen Y; Lu Y; Zhou F; Li C; Zeng Z; Cai W; Lin L; Li Q; Ye M; Dong J; Yin L; Tang D; Zhang G; Dai Y
Front Oncol; 2021; 11():727752. PubMed ID: 34692502
[TBL] [Abstract][Full Text] [Related]
13. Association between the expression of core 3 synthase and survival outcomes of patients with cholangiocarcinoma.
Boottanun P; Ino Y; Shimada K; Hiraoka N; Angata K; Narimatsu H
Oncol Lett; 2021 Nov; 22(5):760. PubMed ID: 34539864
[TBL] [Abstract][Full Text] [Related]
14. Mucin-Type O-GalNAc Glycosylation in Health and Disease.
Bagdonaite I; Pallesen EMH; Nielsen MI; Bennett EP; Wandall HH
Adv Exp Med Biol; 2021; 1325():25-60. PubMed ID: 34495529
[TBL] [Abstract][Full Text] [Related]
15. Display of the human mucinome with defined O-glycans by gene engineered cells.
Nason R; Büll C; Konstantinidi A; Sun L; Ye Z; Halim A; Du W; Sørensen DM; Durbesson F; Furukawa S; Mandel U; Joshi HJ; Dworkin LA; Hansen L; David L; Iverson TM; Bensing BA; Sullam PM; Varki A; Vries E; de Haan CAM; Vincentelli R; Henrissat B; Vakhrushev SY; Clausen H; Narimatsu Y
Nat Commun; 2021 Jul; 12(1):4070. PubMed ID: 34210959
[TBL] [Abstract][Full Text] [Related]
16. The Role of Glycosyltransferases in Colorectal Cancer.
Fernández-Ponce C; Geribaldi-Doldán N; Sánchez-Gomar I; Quiroz RN; Ibarra LA; Escorcia LG; Fernández-Cisnal R; Martinez GA; García-Cózar F; Quiroz EN
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070747
[TBL] [Abstract][Full Text] [Related]
17. Mucins as anti-cancer targets: perspectives of the glycobiologist.
Brockhausen I; Melamed J
Glycoconj J; 2021 Aug; 38(4):459-474. PubMed ID: 33704667
[TBL] [Abstract][Full Text] [Related]
18. Research progress on O-GlcNAcylation in the occurrence, development, and treatment of colorectal cancer.
Liu Y; Peng FX
World J Gastrointest Surg; 2021 Feb; 13(2):96-115. PubMed ID: 33643531
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological significance of core 3 O-glycan synthetic enzyme, β1,3-N-acetylglucosaminyltransferase 6 in pancreatic ductal adenocarcinoma.
Doi N; Ino Y; Angata K; Shimada K; Narimatsu H; Hiraoka N
PLoS One; 2020; 15(11):e0242851. PubMed ID: 33253272
[TBL] [Abstract][Full Text] [Related]
20. Cancer-associated hypersialylated MUC1 drives the differentiation of human monocytes into macrophages with a pathogenic phenotype.
Beatson R; Graham R; Grundland Freile F; Cozzetto D; Kannambath S; Pfeifer E; Woodman N; Owen J; Nuamah R; Mandel U; Pinder S; Gillett C; Noll T; Bouybayoune I; Taylor-Papadimitriou J; Burchell JM
Commun Biol; 2020 Nov; 3(1):644. PubMed ID: 33149188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
